[Skip to Navigation]
Sign In
Table 1. Lifetime Prevalence of Gambling Involvement and Disordered Gambling Classifications Among 4764 Adult Australian Twins
Lifetime Prevalence of Gambling Involvement and Disordered Gambling Classifications Among 4764 Adult Australian Twins
Table 2. Twin Correlations in Liability for Disordered Gambling
Twin Correlations in Liability for Disordered Gambling
Table 3. Parameter Estimates From Biometric Model-Fitting of Sources of Variation in Liability for Disordered Gambling
Parameter Estimates From Biometric Model-Fitting of Sources of Variation in Liability for Disordered Gambling
1.
Black  DWMonahan  POTemkit  MShaw  M A family study of pathological gambling.  Psychiatry Res 2006;141 (3) 295- 303PubMedGoogle ScholarCrossref
2.
Slutske  WSEisen  SATrue  WRLyons  MJGoldberg  JTsuang  MT Common genetic vulnerability for pathological gambling and alcohol dependence in men.  Arch Gen Psychiatry 2000;57 (7) 666- 673PubMedGoogle ScholarCrossref
3.
Eisen  SALin  NLyons  MJScherrer  JGriffith  KTrue  WRGoldberg  JTsuang  MT Familial influences on gambling behavior: an analysis of 3,359 twin pairs.  Addiction 1998;93 (9) 1375- 1384PubMedGoogle ScholarCrossref
4.
Shaffer  HJHall  MNVander Bilt  J Estimating the prevalence of disordered gambling behavior in the United States and Canada: a meta-analysis.  Harvard Medical School Division on Addictions; 1997. http://www.divisiononaddictions.org/html/publications/meta.pdf. Accessed March 18, 2010
5.
Blanco  CHasin  DSPetry  NStinson  FSGrant  BF Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey of Alcohol and Related Conditions.  Psychol Med 2006;36 (7) 943- 953PubMedGoogle ScholarCrossref
6.
Kessler  RCHwang  ILaBrie  RPetukhova  MSampson  NAWinters  KCShaffer  HJ DSM-IV pathological gambling in the National Comorbidity Survey Replication.  Psychol Med 2008;38 (9) 1351- 1360PubMedGoogle ScholarCrossref
7.
Crisp  BRThomas  SAJackson  ACSmith  SBorrell  JHo  WYHolt  TAThomason  N Not the same: a comparison of female and male clients seeking treatment from problem gambling counselling services.  J Gambl Stud 2004;20 (3) 283- 299PubMedGoogle ScholarCrossref
8.
Petry  NM Pathological Gambling: Etiology, Comorbidity, and Treatment.  Washington, DC: American Psychological Association; 2005
9.
Slutske  WS Natural recovery and treatment-seeking in pathological gambling: results of two US national surveys.  Am J Psychiatry 2006;163 (2) 297- 302PubMedGoogle ScholarCrossref
10.
Slutske  WSBlaszczynski  AMartin  NG Sex differences in the rates of recovery, treatment-seeking, and natural recovery in pathological gambling: results from an Australian community-based twin survey.  Twin Res Hum Genet 2009;12 (5) 425- 432PubMedGoogle ScholarCrossref
11.
National Research Council Pathological Gambling: A Critical Review.  Washington, DC: National Academy Press; 1999
12.
Martins  SSLobo  DSSTavares  HGentil  V Pathological gambling in women: a review.  Rev Hosp Clin Fac Med Sao Paulo 2002;57 (5) 235- 242PubMedGoogle ScholarCrossref
13.
Walters  GD Behavior genetic research on gambling and problem gambling: a preliminary meta-analysis of available data.  J Gambl Stud 2001;17 (4) 255- 271PubMedGoogle ScholarCrossref
14.
Winters  KCRich  T A twin study of adult gambling behavior.  J Gambl Stud 1998;14 (3) 213- 225Google ScholarCrossref
15.
Ibáñez  ABlanco  CPerez de Castro  IFernandez-Piqueras  JSaiz-Ruiz  J Genetics of pathological gambling.  J Gambl Stud 2003;19 (1) 11- 22PubMedGoogle ScholarCrossref
16.
Rutter  MCaspi  AMoffitt  TE Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies.  J Child Psychol Psychiatry 2003;44 (8) 1092- 1115PubMedGoogle ScholarCrossref
17.
Lobo  DSKennedy  JL Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities.  Addiction 2009;104 (9) 1454- 1465PubMedGoogle ScholarCrossref
18.
Patsopoulos  NATatsioni  AIoannidis  JPA Claims of sex differences: an empirical assessment in genetic associations.  JAMA 2007;298 (8) 880- 893PubMedGoogle ScholarCrossref
19.
Shaffer  HJHall  MNVander Bilt  J Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis.  Am J Public Health 1999;89 (9) 1369- 1376PubMedGoogle ScholarCrossref
20.
Heath  ACSlutske  WSMadden  PAF Gender differences in the genetic contribution to alcoholism risk and to alcohol consumption patterns. In: Wilsnack  RW, Wilsnack  SC, eds.  Gender and Alcohol. Piscataway, NJ: Rutgers University Press; 1997Google Scholar
21.
Prescott  CA Sex differences in the genetic risk for alcoholism.  Alcohol Res Health 2002;26 (4) 264- 273PubMedGoogle Scholar
22.
Sullivan  PFNeale  MCKendler  KS Genetic epidemiology of major depression: review and meta-analysis.  Am J Psychiatry 2000;157 (10) 1552- 1562PubMedGoogle ScholarCrossref
23.
Slutske  WSMeier  MHZhu  GStatham  DJBlaszczynski  AMartin  NG The Australian twin study of gambling (OZ-GAM): rationale, sample description, predictors of participation, and a first look at sources of individual differences in gambling involvement.  Twin Res Hum Genet 2009;12 (1) 63- 78PubMedGoogle ScholarCrossref
24.
Gerstein  DHoffmann  JPLarison  CEngelman  LMurphy  SPalmer  A  et al Gambling Impact and Behavior Study: Report to the National Gambling Impact Study Commission.  New York, NY: Christiansen/Cummings Associates; 1999
25.
Muthén  LKMuthén  B Mplus User's Guide.  Los Angeles, CA: Muthén and Muthén; 1998-2004
26.
Neale  MCLubke  GAggen  SHDolan  CV Problems with using sum scores for estimating variance components: contamination and measurement noninvariance.  Twin Res Hum Genet 2005;8 (6) 553- 568PubMedGoogle ScholarCrossref
27.
Neale  MCBoker  SMXie  GMaes  HH Mx: Statistical Modeling. 6th ed. Richmond, VA: Virginia Commonwealth Department of Psychiatry; 2003
28.
Neale  MCCardon  LR Methodology for Genetic Studies of Twins and Families.  Dordrecht, the Netherlands: Kluwer Academic Publishers; 1992
29.
Kendler  KS Twin studies of psychiatric illness: current status and future directions.  Arch Gen Psychiatry 1993;50 (11) 905- 915PubMedGoogle ScholarCrossref
30.
Xian  HScherrer  JFSlutske  WSShah  KRVolberg  REisen  SA Genetic and environmental contributions to pathological gambling symptoms in a 10-year follow-up.  Twin Res Hum Genet 2007;10 (1) 174- 179PubMedGoogle ScholarCrossref
31.
Strong  DRKahler  CW Evaluation of the continuum of gambling problems using the DSM-IV Addiction 2007;102 (5) 713- 721PubMedGoogle ScholarCrossref
32.
Reich  RCloninger  CRGuze  SB The multifactorial model of disease transmission, I: description of the model and its use in psychiatry.  Br J Psychiatry 1975;1271- 10PubMedGoogle ScholarCrossref
33.
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987
34.
McGuffin  PRiley  BPlomin  R Genomics and behavior: toward behavioral genomics.  Science 2001;291 (5507) 1232- 1249PubMedGoogle ScholarCrossref
35.
Jinks  JLFulker  DW Comparison of the biometrical genetical, MAVA, and classical approaches to the analysis of human behavior.  Psychol Bull 1970;73 (5) 311- 349PubMedGoogle ScholarCrossref
36.
Eaves  LJLast  KAMartin  NGJinks  JL A progressive approach to non-additivity and genotype-environmental covariance in the analysis of human differences.  Br J Math Stat Psychol 1977;301- 42Google ScholarCrossref
37.
Plomin  RDeFries  JCLoehlin  JC Genotype environment interaction and correlation in the analysis of human behavior.  Psychol Bull 1977;84 (2) 309- 322PubMedGoogle ScholarCrossref
38.
Scarr  SMcCartney  K How people make their own environments: a theory of genotype greater than environment effects.  Child Dev 1983;54 (2) 424- 435PubMedGoogle Scholar
39.
Comings  DERosenthal  RJLesieur  HRRugle  LJMuhleman  DChiu  CDietz  GGade  R A study of the dopamine D2 receptor gene in pathological gambling.  Pharmacogenetics 1996;6 (3) 223- 234PubMedGoogle ScholarCrossref
40.
Comings  DEGade  RWu  SChiu  CDietz  GMuhleman  DSaucier  GFerry  LRosenthal  RJLesieur  HRRugle  LJMacMurray  P Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors.  Mol Psychiatry 1997;2 (1) 44- 56PubMedGoogle ScholarCrossref
41.
da Silva Lobo  DSVallada  HPKnight  JMartins  SSTavares  HGentil  VKennedy  JL Dopamine genes and pathological gambling in discordant sib-pairs.  J Gambl Stud 2007;23 (4) 421- 433PubMedGoogle ScholarCrossref
42.
Sullivan  PFEaves  LJKendler  KSNeale  MC Genetic case-control association studies in neuropsychiatry.  Arch Gen Psychiatry 2001;58 (11) 1015- 1024PubMedGoogle ScholarCrossref
43.
Smith  LWatson  MGates  SBall  DFoxcroft  D Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review.  Am J Epidemiol 2008;167 (2) 125- 138PubMedGoogle ScholarCrossref
44.
Munafò  MRYalcin  BWillis-Owen  SFlint  J Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data.  Biol Psychiatry 2008;63 (2) 197- 206PubMedGoogle ScholarCrossref
45.
Dodd  MLKlos  KJBower  JHGeda  YEJosephs  KAAhlskog  JE Pathological gambling caused by drugs used to treat parkinson disease.  Arch Neurol 2005;62 (9) 1377- 1381PubMedGoogle ScholarCrossref
46.
Szarfman  ADoraiswamy  PMTonning  JMLevine  JG Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event Database.  Arch Neurol 2006;63 (2) 299- 300PubMedGoogle ScholarCrossref
47.
Crockford  DQuickfall  JCurrie  SFurtado  SSuchowersky  Oel-Guebaly  N Prevalence of problem and pathological gambling in Parkinson's disease.  J Gambl Stud 2008;24 (4) 411- 422PubMedGoogle ScholarCrossref
48.
Tippmann-Peikert  MPark  JGBoeve  BFShepard  JWSilber  MH Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.  Neurology 2007;68 (4) 301- 303PubMedGoogle ScholarCrossref
49.
Agrawal  ALynskey  MT Are there genetic influences on addiction: evidence from family, adoption and twin studies.  Addiction 2008;103 (7) 1069- 1081PubMedGoogle ScholarCrossref
50.
Petry  NMStinson  FSGrant  BF Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.  J Clin Psychiatry 2005;66 (5) 564- 574PubMedGoogle ScholarCrossref
Original Article
June 2010

Genetic and Environmental Influences on Disordered Gambling in Men and Women

Author Affiliations

Author Affiliations: University of Missouri–Columbia, Columbia (Dr Slutske and Ms Meier); and Queensland Institute of Medical Research, Brisbane, Australia (Drs Zhu and Martin).

Arch Gen Psychiatry. 2010;67(6):624-630. doi:10.1001/archgenpsychiatry.2010.51
Abstract

Context  Women now represent nearly half of all individuals in treatment for pathological gambling (PG), but relatively little is known about the causes of PG among women or potential sex differences in the causes of PG.

Objectives  To (1) investigate the role of genetic and environmental risk factors in the development of disordered gambling (DG) among women and (2) determine the extent to which the genetic and environmental risk of DG among women differs quantitatively or qualitatively from the risk of DG among men. (Disordered gambling refers to the full continuum of gambling-related problems that includes PG disorder.)

Design  Twin study.

Setting  The national community-based Australian Twin Registry.

Participants  Four thousand seven hundred sixty-four individuals from 2889 twin pairs; twins were aged 32 to 43 years and 57% were women.

Main Outcome Measure  Disordered gambling was defined based on lifetime DSM-IV PG symptom counts.

Results  The estimate of the proportion of variation in liability for DG due to genetic influences was 49.2% (95% confidence interval, 26.7-60.9). There was no evidence for shared environmental influences contributing to variation in DG liability. There was no evidence for quantitative or qualitative sex differences in the causes of variation in DG liability.

Conclusions  This study establishes for the first time that genes are as important in the etiology of DG in women as they are in men and that the susceptibility genes contributing to variation in liability for DG are likely to overlap considerably in men and women.

Pathological gambling (PG) runs in families.1 In a recent family study, 8% of the first-degree relatives of PG-affected probands, compared with 2% of the first-degree relatives of unaffected controls, had a lifetime history of PG.1 The results of such family studies raise the question of the extent to which the familial transmission of PG can be explained by shared genes or shared environments. To date, only a single study has addressed this question. In the Vietnam Era Twin Registry, 23% of the monozygotic (MZ) and 10% of the dizygotic (DZ) co-twins of men with PG, compared with 1.4% of the full sample, had a lifetime history of PG.2 Biometric modeling revealed that the familial aggregation of PG was mainly attributable to shared genetic rather than shared environmental factors.2,3 Whether the results from the all-male Vietnam Era Twin Registry study can be generalized to women has still not been established.

Although women are outnumbered by men approximately 2-fold in their probability of being affected with PG,4-6 they now represent nearly half of all individuals in treatment for the disorder.7-10 Despite this, women are still underrepresented in most etiologic research,11,12 and the familial transmission of PG among women and potential sex differences in the familial transmission of PG are largely uncharted territory. Given how poorly represented women have been in gambling research, there are only a few modest pieces of evidence to point to: (1) a review of 17 family studies suggested that the familial transmission of PG was weaker for women than for men (although the more recent study cited earlier1 did not detect such a sex difference) and that having a mother affected with PG did not increase the risk of PG in the offspring13; (2) a small twin study of 155 twin pairs (63 female pairs) that concluded that gambling involvement was significantly heritable among men but not among women14; and (3) a genetic association study of 68 individuals with PG (21 women) reported 3 associations that were significant in men but not in women15 (appropriate tests of sex differences16-18 were not always conducted in these early studies). Some have speculated that PG among women may not have genetic underpinnings.13,14

In the present study, we investigated the role of genetic and environmental risk factors in the development of disordered gambling (disordered gambling [DG] refers to the full continuum of gambling-related problems that includes PG as well as subclinical problems19) in a large community-based sample of male, female, and opposite-sex twin pairs. Based on previous twin research on related disorders, we did not expect there to be significant sex differences in the role of genetic and environmental influences in the risk of DG. Meta-analyses of population-based twin studies of alcohol dependence20,21 and major depression22 have yielded very similar estimates of the contribution of genetic and environmental factors for men vs women. Based on these more developed literatures, we hypothesized that the same would also be observed for DG, and the main goal was to establish for the first time that DG has genetic underpinnings in women as well as men. The extent to which the genetic and environmental risk factors differ in men vs women was also explored by comparing twins from same- and opposite-sex twin pairs.

Methods
Participants

Participants for this study were 4764 members of the Australian Twin Registry Cohort II (details about the study participants and the zygosity determination have been published previously23). In 2004-2007, a telephone interview containing a thorough assessment of gambling behaviors was conducted in the Australian Twin Registry Cohort II members (individual response rate of 80.4%).23 The mean age was 37.7 years (range, 32-43 years), and 57.2% of the sample was female. There were 1875 complete twin pairs (867 MZ pairs [520 female and 347 male] and 1008 DZ pairs [367 female/female, 227 male/male, and 414 female/male]), and 1014 individual twins from incomplete pairs (304 MZ individuals [151 female and 153 male] and 710 DZ individuals [181 women from female/female pairs, 216 men from male/male pairs, and 207 women and 106 men from female/male pairs]).

Procedure

Twins were assessed through a structured telephone interview. Interviews were administered by trained lay interviewers who were blind to the status of the co-twin. Interviewers were supervised by a project coordinator, a clinical psychologist with more than 10 years of experience. All interview protocols were reviewed either by the project coordinator or by research editors (veteran, skilled interviewers from previous studies who had maintained consistently low error rates in coding). All interviews were tape-recorded and a random sample of 5% of the interview tapes was reviewed for quality control and coding inconsistencies. A small subsample of the participants (n = 166) were reinterviewed several months after their initial interview (mean interval, 3.4 months [SD, 1.4 months]; range, 1.2-9.5 months) to establish the test-retest reliability of the interview measures. Individuals with a history of PG symptoms were oversampled for the test-retest reliability study. The institutional review boards at the University of Missouri–Columbia and the Queensland Institute of Medical Research approved this study. All of the participants provided informed consent.

Measures
Disordered Gambling

The National Opinion Research Center DSM-IV Screen for Gambling Problems (NODS)24 was used to assess DG. The NODS DSM-IV diagnostic criteria were assessed for all participants who reported that they had ever gambled at least 5 times within a single 12-month period; most participants (77.5%) surpassed this gambling threshold.

The NODS is a structured interview that was developed for a national United States gambling prevalence survey conducted in 1999.24 The NODS assesses the 10 DSM-IV diagnostic criteria for PG. The test-retest reliability of the lifetime diagnosis of PG from the NODS was high (κ = 0.67; Yule Y = 0.79). Exploratory factor analyses provided strong and convincing evidence consistent with a single-factor model of PG for the DSM-IV symptom set: there was only a single large eigenvalue greater than 1, and the root mean square error of approximation and root mean square residual were 0.021 and 0.03, respectively. Typically, a single eigenvalue greater than 1, a root mean square error of approximation of less than 0.06, a root mean square residual of less than 0.05, and all of the indicators having high loadings on a single factor support the hypothesis that a single factor is sufficient for explaining the interitem correlations. The exploratory factor analyses support the proposition that all of the DSM-IV symptoms are measuring the same underlying dimension and that endorsing even a single item is informative about an individual's DG liability.

Because the DSM-IV diagnostic criteria for PG also include an exclusion criterion that the “gambling behavior is not better accounted for by a manic episode,” a mania screen was also included in the interview. Participants who endorsed having a period of unusually elevated mood accompanied by behaviors noticeable to others (rapid speech and impulsive behaviors) and treatment (hospitalization or medication) were considered to have probable mania; 1.2% of the sample met these criteria. This included 6 individuals with DSM-IV PG. Only 2 of the 6 individuals with DSM-IV PG who were classified with probable mania reported that there was an increase in the frequency and quantity of gambling expenditures during the manic episode. Because there were so few individuals who met this criterion for exclusion, and to maintain consistency with previous research (this exclusion was a new addition to the DSM-IV), we retained these individuals in the sample.

Environmental Similarity

Data obtained from a previous structured telephone interview23 conducted in 1996-2000 (on average 7.8 years prior to the present study when the participants were aged 24-36 years) were used to evaluate the validity of the equal environmental similarity assumption of twin studies for DG. Childhood environmental similarity was assessed with 4 questions. Each twin was asked how often they (1) shared the same friends when they were aged 6 to 13 years, (2) dressed alike when they were aged 6 to 13 years, and were in the same classes in (3) primary school or (4) high school. The responses from twins within pairs were combined for each item, and the 4 items were combined into a composite indicator of childhood similarity. Adult environmental similarity was assessed with 2 questions. Each twin was asked how often they (1) saw each other or (2) contacted each other by letter, e-mail, fax, or telephone. The responses from twins within pairs were combined for each item, and the 2 items were combined into a composite indicator of adult environmental similarity.

Statistical analysis

Prior to conducting biometric modeling, we tested for cross-sex measurement invariance of DG as measured by the 10 DSM-IV PG symptoms. This was done to ensure that any sex differences that emerged in the biometric analyses could be interpreted as actual sex differences in DG, rather than sex differences in our chosen measurement of DG. The analyses were conducted using Mplus software25 with a mean- and variance-adjusted weighted least-squares estimator. Measurement invariance analyses were conducted using the methods detailed by Neale et al.26

Biometric models were fit by the method of maximum likelihood directly to the raw twin data using the Mx program,27 using data from incomplete as well as complete twin pairs. Liability-threshold models were fit to the twin data.28,29 This model assumes that there are latent liability continua underlying the categorical diagnoses. The decision to use this model was based on the following 2 considerations: (1) maintaining consistency with the previous twin study of DG,2,3,30 and (2) the use of a continuous symptom count measure was intractable because the distribution was highly skewed even after a data transformation.

In fitting a liability-threshold model, a decision must be made about the appropriate threshold to use. Typically, this will correspond to whether or not an individual is affected vs unaffected with a disorder. However, with dimensional diagnoses such as PG, this diagnostic cutoff also represents a count on a continuous symptom scale (ie, 5 of 10 symptoms for DSM-IV PG). When the symptoms making up the scale are all indicators of the same unidimensional construct, as indicated by the exploratory factor analyses and previous research,31 the cutoff used for the threshold in the liability-threshold model does not necessarily have to correspond to the cutoff used for a clinical diagnosis. The liability-threshold model assumes that the causes of variation in risk will be the same at any point along the liability distribution and for any threshold imposed.32 Therefore, to maximize the statistical power, we dichotomized the DSM-IV symptom counts at 1 or more symptoms. Although this threshold conforms most closely to the idea of problem gambling, the assumption of the underlying model that we are imposing suggests that the results will apply equally to all levels of disordered gambling behavior, including PG.

Biometric model fitting was conducted to partition the variation in DG liability into additive genetic, shared environmental or nonadditive genetic, and nonshared environmental influences (estimates of nonshared environmental variation will also include measurement error). The evidence for 2 different types of sex difference was evaluated. Quantitative (also known as scalar) sex differences refer to differences in the magnitude of genetic or environmental effects in men and women and are detected from within-zygosity differences in the twin correlations obtained from same-sex male vs female twin pairs. Qualitative (also known as nonscalar) sex differences refer to differences in the actual genetic or environmental risk factors that contribute to variation in a trait and are detected from smaller twin correlations obtained from opposite-sex than from same-sex DZ twin pairs.

Ideally, one would combine the measurement model used in the measurement invariance analyses with the biometric models.26 Unfortunately, the sparseness of some of the DSM-IV PG symptom data among some of the 5 sex/zygosity subgroupings precluded the implementation of this analytic approach.

Results

Many of the participants were frequent gamblers. Nearly all of the participants had ever gambled, about one-half had gambled at least once a month, and about one-third had gambled at least once a week (Table 1). The overall lifetime prevalence of PG according to the DSM-IV was 2.2% (3.4% among men and 1.2% among women). The overall lifetime prevalence of ever experiencing 1 or more DSM-IV PG symptoms was 12.5% (18.2% among men and 8.3% among women).

Tests of measurement invariance

Of the 10 DSM-IV PG symptoms, 1 had to be excluded from the cross-sex measurement invariance analyses owing to low rates of endorsement in both sexes (committing illegal acts to finance gambling). The remaining 9DSM-IV PG symptoms were factor analyzed, and the fit of the baseline single-factor model of these 9 symptoms, allowing all measurement parameters to differ for men and women, was quite good (comparative fit index = 0.99, Tucker Lewis Index = 0.99, root mean square error of approximation = 0.02). When the factor loading and threshold for a single symptom were allowed to differ for men and women, the fit of a constrained model no longer differed from the unconstrained model (Δχ25 = 4.29, P = .51, n = 4764), suggesting partial measurement invariance of the DSM-IV PG symptoms across sex.

The measurement noninvariance of the single symptom “gambles to escape personal problems or to relieve a dysphoric mood” is consistent with significant differences in the prevalence of this individual DSM-IV PG symptom in men and women in general population surveys,5 in treatment samples,7 and with a previous analysis that also showed that this symptom functioned differentially for men and women.31 This differential item functioning across men and women is an undesirable quality in a diagnostic criterion and warrants a reevaluation of the DSM-IV PG criteria set.

Tests of sex differences

Prior to fitting biometric models, tests of the differences between the twin correlations for the different zygosity groups were conducted using Mx (Table 2). In these and all subsequent biometric models, thresholds (prevalences) for men and women were allowed to vary because they could not be constrained to be equal (Δχ21 = 92.4, P < .001, n = 4758). The twin correlations from both the 2 MZ groups (male and female) and the 2 same-sex DZ groups (male/male and female/female) could be constrained to be equal (Δχ22 = 0.07, P = .97, n = 4759), and the 3 correlations from the 2 same-sex DZ groups and the opposite-sex DZ group (male/male, female/female, and male/female) could also be constrained to be equal (Δχ21 = 0.00, P = .95, n = 4760).

These results indicate that there is no evidence of quantitative sex differences or qualitative sex differences. Based on these findings, it would be appropriate to proceed with biometric modeling without allowing for sex differences in parameter estimates; but because there are so few data on the etiology of DG among women, we present results of fitting models to the male and female data separately in addition to fitting models to the pooled data from men and women.

Biometric model fitting

The best fitting model was one that included additive genetic and nonshared environmental sources of variation. Shared environmental or nonadditive genetic factors did not account for significant portions of variation in liability. The results of fitting a full univariate biometric model that included additive genetic, shared environmental, and nonshared environmental sources of variation are presented in Table 3 for the purpose of delineating the confidence bounds around the parameter estimates (of the nonsignificant as well as the significant parameters). For example, shared environmental factors were estimated at 0, but the narrow confidence interval (CI) around this estimate suggests that shared environmental factors could have accounted for only 4% of the variation in liability at best. Parameter estimates for men and women did not significantly differ from each other (Δχ22 = 0.1, P = .97, n = 4760).

As a check on the validity of the underlying assumption of the liability-threshold model, we compared the heritability estimates obtained from fitting full univariate biometric models to the data from the full sample when the diagnostic cutoffs were set at 1 or more, 3 or more, or 5 or more symptoms (the latter cutoff corresponds to a diagnosis of DSM-IV PG). This yielded heritability estimates of 49% (95% CI, 28%-61%; Table 3), 58% (95% CI, 35%-78%), and 40% (95% CI, 9%-74%), respectively. These results are consistent with the hypothesis that the causes of variation in risk are similar at any point along the DG liability distribution and for any diagnostic cutoff imposed.

Tests of the equal environmental similarity assumption

As a check on the underlying equal environment assumption of the twin method, we conducted logistic regressions predicting twin pair concordance for DG from childhood similarity of experiences (sharing the same friends, dressing alike, being in the same classes in primary school, and being in the same classes in high school) or frequency of contact as adults. After controlling for sex, age, and zygosity, neither childhood environmental similarity nor adult frequency of contact significantly predicted twin pair concordance for DG. This suggests that the equal environment assumption holds for DG in this study. The greater similarity of MZ than DZ twins is more likely attributable to greater sharing of genes rather than to greater sharing of environments.

Comment

There has been very little behavioral genetic research on DG to date. This investigation represents only the second twin study of DG among men and the first twin study of DG among women. The previous Vietnam Era Twin Registry study of DG3 was based on a national US sample of men who were 42 years of age on average (range, 33-53 years) when the data were collected in 1991-1992; its assessment of DG was based on the DSM-III-R criteria.33 The present study included a national Australian sample of men who were 38 years of age on average (range, 32-43 years) when the data were collected in 2004-2007 and used an assessment of DG based on the DSM-IV criteria. Eisen et al3 also fit a liability-threshold model to the categorical DG diagnostic data and presented results based on using different cutoffs (ie, ≥1, ≥2, ≥3, and ≥4 DSM-III-R PG symptoms). The cutoff of 1 or more symptoms most closely matches the DG analyses in the present article. Based on this operationalization in the US study, the estimates of variation in DG liability due to additive genetic, shared environmental, and nonshared environmental influences were 48%, 0%, and 52%, respectively, which is nearly identical to the estimates for men in the present study (Table 3).

Neither the Vietnam Era Twin Registry study nor the present study obtained evidence of shared environmental influences contributing to variation in DG liability. This is similar to the results obtained from meta-analyses of population-based twin studies of alcohol dependence20,21 and major depression.22 In fact, decades of quantitative genetic research on psychopathology, personality, and cognition have consistently found that shared environmental factors do not explain significant portions of phenotypic variation for most traits.34

This is not to say that shared family environmental factors may not be important in the development of DG. The effect of such environmental factors may be genotype dependent (ie, genotype × environment interaction),35-37 or the exposure to such environmental factors may be correlated with genetic differences (ie, genotype × environment correlation),37,38 and in many instances these types of environmental effects will be apportioned to the genetic source of variation in biometric twin models.36 An exemplar genotype × shared environment correlation for DG arises when a child is raised by a biological parent with a gambling problem. In this scenario, the child is potentially exposed to a problem gambling role model and inherits problem gambling susceptibility genes.

Women have been the focus of very little etiologic research on DG, and it is not clear the extent to which most DG research based upon men can be applied to women. In the present study, there was little evidence for sex differences, neither quantitative nor qualitative, in the sources of variation in liability to DG. The contribution of genetic, shared, and nonshared environmental factors to variation in DG liability did not significantly differ between men and women, and the estimated parameters of these effects were very similar. The genetic risk factors implicated in the liability to DG also did not significantly differ between men and women. The results of this study suggest that much of the existing literature on DG that has been based upon research with men might also be generalized to women.

There have been only 11 published molecular genetic studies of DG to date,17 and the studies were based on only 4 independent samples. Altogether, only 518 individuals with DG (mostly men) have been included in molecular genetic investigations of DG. All of the studies have been candidate gene association studies; there has not yet been a genome-wide linkage or association study of DG. The focus of most of the association studies has been 1 or more of the dopamine receptor genes (including DRD1, DRD2, DRD3, DRD4, and DRD5) and the dopamine transporter gene (DAT), with at least 1 positive finding reported for DRD1, DRD2, and DRD4.39-41

Although it is difficult to draw firm conclusions from so few association studies42 of dopamine genes and DG, there are at least 2 other lines of evidence that suggest that the dopamine genes are related to susceptibility for DG. First, meta-analyses of association studies of the DRD2 gene and alcohol dependence43 and the DRD4 C521T polymorphism and novelty seeking44 suggest that there are small but significant associations with these correlated traits. Second, there have been a series of reports on the incidence of DG among individuals with Parkinson disease45-47 and restless legs syndrome48 who were being treated with a dopamine agonist medication in combination with or without levodopa (an amino acid precursor of dopamine) and whose DG usually resolved with the discontinuation of the dopamine agonist therapy.45,48

In searching for susceptibility genes, it will be important to acknowledge the stage-sequential nature of DG.49 Like other addictive disorders, DG requires that one pass through a series of stages, including the participation in gambling activities and progression to regular involvement, prior to the eventual development of DG symptoms. Thus, genetic susceptibility for DG will also include genes related to individual differences in these earlier stages. In a previous article from this sample, we presented evidence for significant genetic influences for a variety of indices of gambling involvement, including the number of different gambling activities ever tried, the frequency of gambling, and the maximum amount ever bet, with heritabilities ranging from 43% to 56%.24 It has not yet been established the extent to which the genes related to individual differences in gambling participation contribute to the genetic risk of DG, but it is likely that part of the answer will be found with such genes.

This study has a number of limitations. It is unclear how the results of this Australian twin study will generalize to other cultures. Australia was specifically chosen as the site for this study because it has a heavy gambling culture23 and higher prevalences of PG. For example, the lifetime prevalences of DSM-IV PG in this Australian national survey were 3.4% and 1.2% among men and women, respectively, compared with 0.64% and 0.23% among men and women in a recent national US survey.50 The univariate model-fitting results for men were similar to the results obtained from the all-male Vietnam Era Twin Registry study, but there are no similar twin studies among women with which to compare our results. Furthermore, like the Vietnam Era Twin Registry study, the age range of the sample was relatively narrow (32-43 years). The extent to which these results can be generalized to other age groups such as adolescents and older individuals remains an unanswered question.

Despite the higher prevalence of PG in this Australian twin sample, it still was necessary to broaden the DG phenotype to have adequate numbers of affected twins to fit sex-limitation models. Supplementary analyses using a diagnostic cutoff of 5 or more symptoms, corresponding to a diagnosis of PG, yielded a heritability estimate that was similar to the results obtained when using the lower DG cutoff of 1 or more symptoms. This supports the assumption of the liability-threshold model and suggests that the results apply to PG disorder as well as the broader DG phenotype that was used throughout this article.

Despite limitations, this study represents a major step forward in that it establishes for the first time that genes are as important in the etiology of DG in women as they are in men. In addition to similar relative contributions of genetic vs environmental factors to variation in liability for DG, the results suggest that the susceptibility genes contributing to variation in liability for DG may also overlap considerably in men and women. Twin studies can only indicate the importance of latent sources of genetic and environmental influence, but are mute concerning the specific genes or environments involved. The discovery of the specific genes and environments involved in the development of DG remains an important direction for future research.

Back to top
Article Information

Correspondence: Wendy S. Slutske, PhD, Department of Psychological Sciences, University of Missouri–Columbia, 210 McAlester Hall, Columbia, MO 65211 (slutskew@missouri.edu).

Submitted for Publication: May 1, 2009; final revision received November 20, 2009; accepted November 23, 2009.

Financial Disclosure: None reported.

Funding/Support: This work was supported by National Institutes of Health grant MH66206.

Additional Contributions: Dixie Statham, MPsychClin, Bronwyn Morris, BSc, and Megan Fergusson, BSc, coordinated the data collection for the twins, and David Smyth, BSc, Olivia Zheng, BSc, and Harry Beeby, BSc, provided data management of the Australian Twin Registry. We thank the Australian Twin Registry twins for their continued participation.

References
1.
Black  DWMonahan  POTemkit  MShaw  M A family study of pathological gambling.  Psychiatry Res 2006;141 (3) 295- 303PubMedGoogle ScholarCrossref
2.
Slutske  WSEisen  SATrue  WRLyons  MJGoldberg  JTsuang  MT Common genetic vulnerability for pathological gambling and alcohol dependence in men.  Arch Gen Psychiatry 2000;57 (7) 666- 673PubMedGoogle ScholarCrossref
3.
Eisen  SALin  NLyons  MJScherrer  JGriffith  KTrue  WRGoldberg  JTsuang  MT Familial influences on gambling behavior: an analysis of 3,359 twin pairs.  Addiction 1998;93 (9) 1375- 1384PubMedGoogle ScholarCrossref
4.
Shaffer  HJHall  MNVander Bilt  J Estimating the prevalence of disordered gambling behavior in the United States and Canada: a meta-analysis.  Harvard Medical School Division on Addictions; 1997. http://www.divisiononaddictions.org/html/publications/meta.pdf. Accessed March 18, 2010
5.
Blanco  CHasin  DSPetry  NStinson  FSGrant  BF Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey of Alcohol and Related Conditions.  Psychol Med 2006;36 (7) 943- 953PubMedGoogle ScholarCrossref
6.
Kessler  RCHwang  ILaBrie  RPetukhova  MSampson  NAWinters  KCShaffer  HJ DSM-IV pathological gambling in the National Comorbidity Survey Replication.  Psychol Med 2008;38 (9) 1351- 1360PubMedGoogle ScholarCrossref
7.
Crisp  BRThomas  SAJackson  ACSmith  SBorrell  JHo  WYHolt  TAThomason  N Not the same: a comparison of female and male clients seeking treatment from problem gambling counselling services.  J Gambl Stud 2004;20 (3) 283- 299PubMedGoogle ScholarCrossref
8.
Petry  NM Pathological Gambling: Etiology, Comorbidity, and Treatment.  Washington, DC: American Psychological Association; 2005
9.
Slutske  WS Natural recovery and treatment-seeking in pathological gambling: results of two US national surveys.  Am J Psychiatry 2006;163 (2) 297- 302PubMedGoogle ScholarCrossref
10.
Slutske  WSBlaszczynski  AMartin  NG Sex differences in the rates of recovery, treatment-seeking, and natural recovery in pathological gambling: results from an Australian community-based twin survey.  Twin Res Hum Genet 2009;12 (5) 425- 432PubMedGoogle ScholarCrossref
11.
National Research Council Pathological Gambling: A Critical Review.  Washington, DC: National Academy Press; 1999
12.
Martins  SSLobo  DSSTavares  HGentil  V Pathological gambling in women: a review.  Rev Hosp Clin Fac Med Sao Paulo 2002;57 (5) 235- 242PubMedGoogle ScholarCrossref
13.
Walters  GD Behavior genetic research on gambling and problem gambling: a preliminary meta-analysis of available data.  J Gambl Stud 2001;17 (4) 255- 271PubMedGoogle ScholarCrossref
14.
Winters  KCRich  T A twin study of adult gambling behavior.  J Gambl Stud 1998;14 (3) 213- 225Google ScholarCrossref
15.
Ibáñez  ABlanco  CPerez de Castro  IFernandez-Piqueras  JSaiz-Ruiz  J Genetics of pathological gambling.  J Gambl Stud 2003;19 (1) 11- 22PubMedGoogle ScholarCrossref
16.
Rutter  MCaspi  AMoffitt  TE Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies.  J Child Psychol Psychiatry 2003;44 (8) 1092- 1115PubMedGoogle ScholarCrossref
17.
Lobo  DSKennedy  JL Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities.  Addiction 2009;104 (9) 1454- 1465PubMedGoogle ScholarCrossref
18.
Patsopoulos  NATatsioni  AIoannidis  JPA Claims of sex differences: an empirical assessment in genetic associations.  JAMA 2007;298 (8) 880- 893PubMedGoogle ScholarCrossref
19.
Shaffer  HJHall  MNVander Bilt  J Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis.  Am J Public Health 1999;89 (9) 1369- 1376PubMedGoogle ScholarCrossref
20.
Heath  ACSlutske  WSMadden  PAF Gender differences in the genetic contribution to alcoholism risk and to alcohol consumption patterns. In: Wilsnack  RW, Wilsnack  SC, eds.  Gender and Alcohol. Piscataway, NJ: Rutgers University Press; 1997Google Scholar
21.
Prescott  CA Sex differences in the genetic risk for alcoholism.  Alcohol Res Health 2002;26 (4) 264- 273PubMedGoogle Scholar
22.
Sullivan  PFNeale  MCKendler  KS Genetic epidemiology of major depression: review and meta-analysis.  Am J Psychiatry 2000;157 (10) 1552- 1562PubMedGoogle ScholarCrossref
23.
Slutske  WSMeier  MHZhu  GStatham  DJBlaszczynski  AMartin  NG The Australian twin study of gambling (OZ-GAM): rationale, sample description, predictors of participation, and a first look at sources of individual differences in gambling involvement.  Twin Res Hum Genet 2009;12 (1) 63- 78PubMedGoogle ScholarCrossref
24.
Gerstein  DHoffmann  JPLarison  CEngelman  LMurphy  SPalmer  A  et al Gambling Impact and Behavior Study: Report to the National Gambling Impact Study Commission.  New York, NY: Christiansen/Cummings Associates; 1999
25.
Muthén  LKMuthén  B Mplus User's Guide.  Los Angeles, CA: Muthén and Muthén; 1998-2004
26.
Neale  MCLubke  GAggen  SHDolan  CV Problems with using sum scores for estimating variance components: contamination and measurement noninvariance.  Twin Res Hum Genet 2005;8 (6) 553- 568PubMedGoogle ScholarCrossref
27.
Neale  MCBoker  SMXie  GMaes  HH Mx: Statistical Modeling. 6th ed. Richmond, VA: Virginia Commonwealth Department of Psychiatry; 2003
28.
Neale  MCCardon  LR Methodology for Genetic Studies of Twins and Families.  Dordrecht, the Netherlands: Kluwer Academic Publishers; 1992
29.
Kendler  KS Twin studies of psychiatric illness: current status and future directions.  Arch Gen Psychiatry 1993;50 (11) 905- 915PubMedGoogle ScholarCrossref
30.
Xian  HScherrer  JFSlutske  WSShah  KRVolberg  REisen  SA Genetic and environmental contributions to pathological gambling symptoms in a 10-year follow-up.  Twin Res Hum Genet 2007;10 (1) 174- 179PubMedGoogle ScholarCrossref
31.
Strong  DRKahler  CW Evaluation of the continuum of gambling problems using the DSM-IV Addiction 2007;102 (5) 713- 721PubMedGoogle ScholarCrossref
32.
Reich  RCloninger  CRGuze  SB The multifactorial model of disease transmission, I: description of the model and its use in psychiatry.  Br J Psychiatry 1975;1271- 10PubMedGoogle ScholarCrossref
33.
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987
34.
McGuffin  PRiley  BPlomin  R Genomics and behavior: toward behavioral genomics.  Science 2001;291 (5507) 1232- 1249PubMedGoogle ScholarCrossref
35.
Jinks  JLFulker  DW Comparison of the biometrical genetical, MAVA, and classical approaches to the analysis of human behavior.  Psychol Bull 1970;73 (5) 311- 349PubMedGoogle ScholarCrossref
36.
Eaves  LJLast  KAMartin  NGJinks  JL A progressive approach to non-additivity and genotype-environmental covariance in the analysis of human differences.  Br J Math Stat Psychol 1977;301- 42Google ScholarCrossref
37.
Plomin  RDeFries  JCLoehlin  JC Genotype environment interaction and correlation in the analysis of human behavior.  Psychol Bull 1977;84 (2) 309- 322PubMedGoogle ScholarCrossref
38.
Scarr  SMcCartney  K How people make their own environments: a theory of genotype greater than environment effects.  Child Dev 1983;54 (2) 424- 435PubMedGoogle Scholar
39.
Comings  DERosenthal  RJLesieur  HRRugle  LJMuhleman  DChiu  CDietz  GGade  R A study of the dopamine D2 receptor gene in pathological gambling.  Pharmacogenetics 1996;6 (3) 223- 234PubMedGoogle ScholarCrossref
40.
Comings  DEGade  RWu  SChiu  CDietz  GMuhleman  DSaucier  GFerry  LRosenthal  RJLesieur  HRRugle  LJMacMurray  P Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors.  Mol Psychiatry 1997;2 (1) 44- 56PubMedGoogle ScholarCrossref
41.
da Silva Lobo  DSVallada  HPKnight  JMartins  SSTavares  HGentil  VKennedy  JL Dopamine genes and pathological gambling in discordant sib-pairs.  J Gambl Stud 2007;23 (4) 421- 433PubMedGoogle ScholarCrossref
42.
Sullivan  PFEaves  LJKendler  KSNeale  MC Genetic case-control association studies in neuropsychiatry.  Arch Gen Psychiatry 2001;58 (11) 1015- 1024PubMedGoogle ScholarCrossref
43.
Smith  LWatson  MGates  SBall  DFoxcroft  D Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review.  Am J Epidemiol 2008;167 (2) 125- 138PubMedGoogle ScholarCrossref
44.
Munafò  MRYalcin  BWillis-Owen  SFlint  J Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data.  Biol Psychiatry 2008;63 (2) 197- 206PubMedGoogle ScholarCrossref
45.
Dodd  MLKlos  KJBower  JHGeda  YEJosephs  KAAhlskog  JE Pathological gambling caused by drugs used to treat parkinson disease.  Arch Neurol 2005;62 (9) 1377- 1381PubMedGoogle ScholarCrossref
46.
Szarfman  ADoraiswamy  PMTonning  JMLevine  JG Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event Database.  Arch Neurol 2006;63 (2) 299- 300PubMedGoogle ScholarCrossref
47.
Crockford  DQuickfall  JCurrie  SFurtado  SSuchowersky  Oel-Guebaly  N Prevalence of problem and pathological gambling in Parkinson's disease.  J Gambl Stud 2008;24 (4) 411- 422PubMedGoogle ScholarCrossref
48.
Tippmann-Peikert  MPark  JGBoeve  BFShepard  JWSilber  MH Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.  Neurology 2007;68 (4) 301- 303PubMedGoogle ScholarCrossref
49.
Agrawal  ALynskey  MT Are there genetic influences on addiction: evidence from family, adoption and twin studies.  Addiction 2008;103 (7) 1069- 1081PubMedGoogle ScholarCrossref
50.
Petry  NMStinson  FSGrant  BF Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.  J Clin Psychiatry 2005;66 (5) 564- 574PubMedGoogle ScholarCrossref
×